MedTrace Logo

Switching to E-cigarette After PCI

NCT06338761 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17973

Last updated 2025-05-21

No results posted yet for this study

Summary

Despite the increasing popularity of electronic cigarettes (E-cigarettes), the prognostic impact of switching to E-cigarettes in smokers with coronary artery disease (CAD) who underwent percutaneous coronary intervention (PCI) remains uncertain.

Conditions

Interventions

BEHAVIORAL

Smoking cessation

Stop smoking

BEHAVIORAL

Switching to E-cigarette

Switching to E-cigarette

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Ki Hong Choi, MD · Samsung Medical Center

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-12-31
Completion
2025-03-15

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06338761 on ClinicalTrials.gov